The US life sciences sector saw a flurry of merger and acquisition activity at the end of 2013, and it may continue into early 2014, according to an analysis from PricewaterhouseCoopers.

Overall, 2013 saw a contraction of 13 percent in medtech sector M&A, with a total of 41 deals, but a surge of 15 deals worth a collective $4.77 billion in the fourth quarter "may signal a healthy turn for the industry," MassDevice reports.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.